Polycystic Ovarian Syndrome: A Complex Disease with a Genetics Approach
- PMID: 35327342
- PMCID: PMC8945152
- DOI: 10.3390/biomedicines10030540
Polycystic Ovarian Syndrome: A Complex Disease with a Genetics Approach
Abstract
Polycystic ovarian syndrome (PCOS) is a complex endocrine disorder affecting females in their reproductive age. The early diagnosis of PCOS is complicated and complex due to overlapping symptoms of this disease. The most accepted diagnostic approach today is the Rotterdam Consensus (2003), which supports the positive diagnosis of PCOS when patients present two out of the following three symptoms: biochemical and clinical signs of hyperandrogenism, oligo, and anovulation, also polycystic ovarian morphology on sonography. Genetic variance, epigenetic changes, and disturbed lifestyle lead to the development of pathophysiological disturbances, which include hyperandrogenism, insulin resistance, and chronic inflammation in PCOS females. At the molecular level, different proteins and molecular and signaling pathways are involved in disease progression, which leads to the failure of a single genetic diagnostic approach. The genetic approach to elucidate the mechanism of pathogenesis of PCOS was recently developed, whereby four phenotypic variances of PCOS categorize PCOS patients into classic, ovulatory, and non-hyperandrogenic types. Genetic studies help to identify the root cause for the development of this PCOS. PCOS genetic inheritance is autosomal dominant but the latest investigations revealed it as a multigene origin disease. Different genetic loci and specific genes have been identified so far as being associated with this disease. Genome-wide association studies (GWAS) and related genetic studies have changed the scenario for the diagnosis and treatment of this reproductive and metabolic condition known as PCOS. This review article briefly discusses different genes associated directly or indirectly with disease development and progression.
Keywords: biochemical; hyperandrogenism; multigene; ovulatory; polycystic.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.Arch Gynecol Obstet. 2006 Jul;274(4):227-32. doi: 10.1007/s00404-006-0173-8. Epub 2006 May 12. Arch Gynecol Obstet. 2006. PMID: 16691383
-
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.Endocr Pract. 2015 Nov;21(11):1291-300. doi: 10.4158/EP15748.DSC. Endocr Pract. 2015. PMID: 26509855
-
Rethinking the Terminology: A Perspective on Renaming Polycystic Ovary Syndrome for an Enhanced Pathophysiological Understanding.Clin Med Insights Endocrinol Diabetes. 2024 Oct 28;17:11795514241296777. doi: 10.1177/11795514241296777. eCollection 2024. Clin Med Insights Endocrinol Diabetes. 2024. PMID: 39494232 Free PMC article.
-
Polycystic Ovary Syndrome.Obstet Gynecol. 2018 Aug;132(2):321-336. doi: 10.1097/AOG.0000000000002698. Obstet Gynecol. 2018. PMID: 29995717 Review.
-
PCOS: a diagnostic challenge.Reprod Biomed Online. 2004 Jun;8(6):644-8. doi: 10.1016/s1472-6483(10)61644-6. Reprod Biomed Online. 2004. PMID: 15169578 Review.
Cited by
-
Metabolic disorders in polycystic ovary syndrome: from gut microbiota biodiversity to clinical intervention.Front Endocrinol (Lausanne). 2025 Apr 28;16:1526468. doi: 10.3389/fendo.2025.1526468. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40357203 Free PMC article. Review.
-
Advances in the understanding of androgen receptor structure and function and in the development of next-generation AR-targeted therapeutics.Steroids. 2024 Oct;210:109486. doi: 10.1016/j.steroids.2024.109486. Epub 2024 Aug 5. Steroids. 2024. PMID: 39111362 Review.
-
The Pathophysiological Mechanism and Clinical Treatment of Polycystic Ovary Syndrome: A Molecular and Cellular Review of the Literature.Int J Mol Sci. 2024 Aug 20;25(16):9037. doi: 10.3390/ijms25169037. Int J Mol Sci. 2024. PMID: 39201722 Free PMC article. Review.
-
Induced Pluripotent Stem Cells as a Possible Approach for Exploring the Pathophysiology of Polycystic Ovary Syndrome (PCOS).Stem Cell Rev Rep. 2024 Jan;20(1):67-87. doi: 10.1007/s12015-023-10627-w. Epub 2023 Sep 28. Stem Cell Rev Rep. 2024. PMID: 37768523 Free PMC article. Review.
-
Immunological and Metabolic Causes of Infertility in Polycystic Ovary Syndrome.Biomedicines. 2023 May 28;11(6):1567. doi: 10.3390/biomedicines11061567. Biomedicines. 2023. PMID: 37371662 Free PMC article. Review.
References
-
- Krysiak R., Okopie B., Gdula-Dymek A., Herman Z.S. Update on the management of polycystic ovary syndrome. Pharmacol. Rep. 2006;58:614. - PubMed
-
- Liu A.L., Xie H.J., Xie H.Y., Liu J., Yin J., Hu J.S., Peng C.Y. Association between fat mass and obesity associated (FTO) gene rs9939609 A/T polymorphism and polycystic ovary syndrome: A systematic review and meta-analysis. BMC Med. Genet. 2017;18:89. doi: 10.1186/s12881-017-0452-1. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources